GL1X · GenesisL1 explorer

MolNFT v1 · #117451 · protein

Crystal structure of human heparanase

5E8M: “Crystal structure of human heparanase”. X-ray diffraction, 3 ligands (NAG, FUC, CL), 4 pockets (best druggability 0.53). MolNFT v1 #117451 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5E8M
Type
protein
Length
459 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Heparanase
EC
3.2.1.166
UniProt
Q9Y251
Ligands
NAG, FUC, CL
Pockets
4 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHeparanase (EC 3.2.1.166)protein38532% helix, 27% strandQ9Y251
BHeparanase (EC 3.2.1.166)protein7432% helix, 32% strandQ9Y251

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains A, B
  • FUC · alpha-L-fucopyranose · sugar · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 15 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12640.530.7534EDO, CL
21390.510.7935EDO
31300.480.7822EDO
4510.280.7513EDO

Interfaces

1 interface between chains.

  • A–B · 4251 Ų buried · 67 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 glycan, 1 disulfide (N-glycosylation, disulfide).

Compared structures

  • 5E8M · Crystal structure of human heparanase · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y251 · AlphaFold monomer V2.0 prediction for heparanase (Q9Y251) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.